COVID-19 has exacerbated gaps in the health care system and highlighted the need for better value-based care. But for some health insurance providers, navigating the shift to value-based care can be tricky and understanding the nuances of new models, like VBID, poses additional challenges.
Better understanding the VBID model can help health insurance providers know what tools they have to leverage—including supplemental benefits for digital health and technology solutions, funding for addressing social determinants of health or med adherence—to better achieve key quality metrics. This webinar will address the key goals and guidelines for the VBID model with key thought leader, Dr. Mark Fendrick with the University of Michigan, and share the role of digital health in successfully navigating the model.
CEO & Co-Founder
As CEO and Co-Founder, Matt Loper oversees strategy, sales, business development, and finance for Wellth. He is inspired by the chance to create scalable positive behavior change in patients with chronic conditions and humbled by the fact that we get to work with some of the best healthcare providers and insurers in the industry.
Prior to founding Wellth, Matt was an investor in publicly traded healthcare technology, medical devices, and services companies at OrbiMed Advisors, a leading healthcare investment firm with $13 billion under management. He also worked in Healthcare Investment Banking at Goldman Sachs.
Matt holds a BS in Biological Engineering from MIT. He is a lifelong fan of the Los Angeles Lakers and played college baseball. He enjoys spending time with his Australian Shepherd, Luna.
Mark Fendrick, MD
Director, Center for Value-Based Insurance Design
University of Michigan, Ann Arbor
A. Mark Fendrick, MD is a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan.
Dr. Fendrick conceptualized and coined the term Value-Based Insurance Design (V-BID) and currently directs the V-BID Center at the University of Michigan, the leading advocate for development, implementation, and evaluation of innovative health benefit plans. His research focuses on how clinician payment and consumer engagement initiatives impact access to care, quality of care, and health care costs. Dr. Fendrick has authored over 250 articles and book chapters and has received numerous awards for the creation and implementation of value-based insurance design.
Dr. Fendrick received his Bachelor’s Degree in Economics & Chemistry from the University of Pennsylvania and his Medical Degree from Harvard Medical School. He completed his residency in internal medicine at the University of Pennsylvania where he was a fellow in the Robert Wood Johnson Foundation Clinical Scholars Program.
Mark A. Atalla, PharmD
Mark Atalla most recently served as a Senior Advisor to the CMS Administrator for Innovation and Drug Pricing, as well as a liaison for Operation Warp Speed. Prior to that, he led the team developing the current iteration of the VBID model, as well as the Part D Senior Savings Model, the Part D Payment Modernization Model, and other CMS Innovation Center models and initiatives. He has a PharmD from the University of Florida and an MBA from the Yale School of Management and, most importantly, a goldendoodle.